Stocks to Sell

Stocks can plunge for any number of reasons — investors may need to raise cash for large milestone purchases, or algorithms could be triggered by stop losses which create massive selloffs. Whatever the case, InvestorPlace’s journalists weed out the markets’ losers, keeping you informed of which stocks to cash out of before they come crashing down.

7 F-Rated Dividend Stocks to Avoid

By Louis Navellier and the InvestorPlace Research Staff
Finding dividend stocks is always a good idea if you're thinking for the long term. Just avoid these seven names in particular.

Why Beyond Meat Stock Remains Beyond Perilous

By Dana Blankenhorn, InvestorPlace Contributor
BYND's quarterly report left a bad aftertaste. The hope for Beyond Meat stock is the company can market and scale its way out of trouble.

Stay Away From iBio, Which Constantly Issues Shares to Survive

By Mark R. Hake, CFA
The latest in IBIO news: stay away from IBIO stock, which has over-issued shares to survive. The stock remains below the average issue price.

3 Reasons to Avoid Nikola Stock as Hype Catches up to the EV Maker

By Faizan Farooque, InvestorPlace Contributor
The Hindenburg Research report exposed several chinks in the EV maker's armor, and NKLA stock will continue its slide to bear the brunt.

Lordstown Motors Didn’t Have Enough Post-IPO Pop to Instill Confidence

By Alex Sirois, InvestorPlace Contributor
RIDE stock hasn't backtracked but it also isn't marching forward as quickly as it may portray, Click for more.

Inovio Gets the Go-Ahead But It’s Probably Too Late

By Will Ashworth, InvestorPlace Contributor
Inovio got the go-ahead from the FDA on Nov. 16 to resume its Phase 2 clinical trial. Is INO stock worth betting on this late in the game?   

It Doesn’t Take Much to Realize ElectraMeccanica Has Reached Absurdity

By InvestorPlace Research Staff
SOLO stock may have jumped into the fast lane, but at some point, it’s going to get pulled over for a speeding ticket it can’t pay.

4 Stocks To Sell If Covid-19 Hurts Oil Demand Again

By Faisal Humayun, InvestorPlace Contributor
Another wave of Covid-19 could result in a double-dip recession, hurting leveraged oil companies. Put these on your list of stocks to sell.

The Post-Earnings Plunge in Beyond Meat Stock Is Not an Opportunity

By InvestorPlace Research Staff
Beyond Meat stock fell 27% after earnings, and some investors might want to buy the dip. But this report mattered, and not in a good way.

With Its Delisting, Dump Hertz Stock at Any Opportunity

By Muslim Farooque, InvestorPlace Contributor
Hertz stock is in shambles after being delisted from the NYSE. The company's debtor-in-possession arrangement is worth nothing to investors.

Virgin Galactic Is Still Far Too Risky At Today’s Prices

By Thomas Niel, InvestorPlace Contributor
Investors may be cutting SPCE stock some slack, but many hurdles remain. Wait for a pullback before buying into Virgin Galactic.

Call it Heresy, But It’s Time to Sell Costco

By Dana Blankenhorn, InvestorPlace Contributor
If you want to sell some stock for Christmas, consider selling some COST stock and spending the money at your nearest Costco.

Why JFrog’s Stock Is Not Very Appealing

By Larry Ramer, InvestorPlace Contributor
The valuation of FROG stock is huge, while reviews of its products are not stellar and it may lack a powerful competitive advantage.

Now Is Not a Time to Gamble on Electrameccanica Vehicles

By Chris Markoch, InvestorPlace Contributor
SOLO stock is soaring as Electrameccanica Vehicles prepares to open a U.S. manufacturing facility. But the question remains if the company is a fad?

McDonald’s Gives Beyond Meat Stock the Cold Shoulder

By Will Ashworth, InvestorPlace Contributor
Beyond Meat got a reality check when McDonald’s announced its McPlant line would launch in 2021. The news pummeled Beyond Meat stock. 

Wait on Investor Rotation for Zoom Video

By Dana Blankenhorn, InvestorPlace Contributor
If you have made money on ZM stock, sell it and wait to see its long term growth rate, then calculate the value of that growth.

Don’t Chase the Current Rally of Workhorse Stock

By Joel Baglole, InvestorPlace Contributor
After falling 50% between late September and the end of October, WKHS stock appears to now be rebounding, leaving investors to ask if they believe the current rally will last.

Inovio Pharmaceutical’s FDA Plight Makes It a Highly Risky Bet

By Muslim Farooque, InvestorPlace Contributor
INO stock has tumbled in the past few months. Inovio needs the FDA to bail it out by allowing the advanced trials of its vaccine to begin.

Don’t Buy the Latest Rally in Exxon Mobil — It’s a Dinosaur

By Louis Navellier and the InvestorPlace Research Staff
XOM stock shares may have staged a late fall rally, but that does not mean Exxon Mobil is at the start of a meaningful recovery.
Load More Articles